M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.89 USD -1.35% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MoonLake Immunotherapeutics
Revenue Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Revenue
$69.6m
CAGR 3-Years
N/A
CAGR 5-Years
129%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Revenue
CHf15.5m
CAGR 3-Years
96%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Revenue
$202.8m
CAGR 3-Years
-39%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Revenue
CHf10.4m
CAGR 3-Years
19%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Revenue
CHf988.4k
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Revenue?
Revenue
0 USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Revenue amounts to 0 USD.

Back to Top